Walter J Scott

Summary

Affiliation: Fox Chase Cancer Center
Country: USA

Publications

  1. ncbi A comparison of perioperative outcomes of Video-Assisted Thoracic Surgical (VATS) Lobectomy with open thoracotomy and lobectomy: Results of an analysis using propensity score based weighting
    Walter J Scott
    Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA
    Ann Surg Innov Res 4:1. 2010
  2. ncbi Video-assisted thoracic surgery versus open lobectomy for lung cancer: a secondary analysis of data from the American College of Surgeons Oncology Group Z0030 randomized clinical trial
    Walter J Scott
    Fox Chase Cancer Center, Department of Surgical Oncology, 7701 Burholme Avenue, Philadelphia, PA 19111, USA
    J Thorac Cardiovasc Surg 139:976-81; discussion 981-3. 2010
  3. ncbi Morbidity and mortality are not increased after induction chemoradiotherapy followed by esophagectomy in patients with esophageal cancer
    Adam C Berger
    Department of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA
    Semin Oncol 32:S16-20. 2005
  4. ncbi Treatment of non-small cell lung cancer stage I and stage II: ACCP evidence-based clinical practice guidelines (2nd edition)
    Walter J Scott
    Fox Chase Cancer Center Suite C 312, 333 Cottman Ave, Philadelphia, PA 19111, USA
    Chest 132:234S-242S. 2007
  5. ncbi Radiofrequency ablation of lung malignancies
    Christophe L Nguyen
    Department of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111-2497, USA
    Ann Thorac Surg 82:365-71. 2006
  6. ncbi The surgical management of superior sulcus tumors: a retrospective review with long-term follow-up
    Melvyn Goldberg
    Department of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111 2497, USA
    Ann Thorac Surg 79:1174-9. 2005
  7. ncbi Complete response to neoadjuvant chemoradiotherapy in esophageal carcinoma is associated with significantly improved survival
    Adam C Berger
    Department of Surgical Oncology, and Division of Biostatistics, Fox Chase Cancer Center, 333 Cottman Ave, Philadelphia, PA 19111, USA
    J Clin Oncol 23:4330-7. 2005
  8. ncbi Radiofrequency ablation of primary lung cancer: results from an ablate and resect pilot study
    Christophe L Nguyen
    Department of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, PA 19111-2497, USA
    Chest 128:3507-11. 2005
  9. ncbi Treatment of stage II non-small cell lung cancer
    Walter J Scott
    Department of Surgical Oncology, Section of Thoracic Surgical Oncology, Fox Chase Cancer Center, 7701 Burholme Avenue, Philadelphia, PA 19111, USA
    Chest 123:188S-201S. 2003
  10. ncbi Surgical treatment of other bronchial tumors
    Walter J Scott
    Department of Surgical Oncology, Section of Thoracic Surgical Oncology, Fox Chase Cancer Center, 7701 Burholme Avenue, Philadelphia, PA 19111, USA
    Chest Surg Clin N Am 13:111-28. 2003

Detail Information

Publications14

  1. ncbi A comparison of perioperative outcomes of Video-Assisted Thoracic Surgical (VATS) Lobectomy with open thoracotomy and lobectomy: Results of an analysis using propensity score based weighting
    Walter J Scott
    Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA
    Ann Surg Innov Res 4:1. 2010
    ....
  2. ncbi Video-assisted thoracic surgery versus open lobectomy for lung cancer: a secondary analysis of data from the American College of Surgeons Oncology Group Z0030 randomized clinical trial
    Walter J Scott
    Fox Chase Cancer Center, Department of Surgical Oncology, 7701 Burholme Avenue, Philadelphia, PA 19111, USA
    J Thorac Cardiovasc Surg 139:976-81; discussion 981-3. 2010
    ..We compared outcomes from participants in a randomized study comparing lymph node sampling versus dissection for early-stage lung cancer who underwent either video-assisted thoracoscopic or open lobectomy...
  3. ncbi Morbidity and mortality are not increased after induction chemoradiotherapy followed by esophagectomy in patients with esophageal cancer
    Adam C Berger
    Department of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA
    Semin Oncol 32:S16-20. 2005
    ..5 days). Esophagectomy can be performed safely with low mortality and acceptable morbidity following neoadjuvant chemotherapy and radiation with no increase in hospital stay for patients with complications...
  4. ncbi Treatment of non-small cell lung cancer stage I and stage II: ACCP evidence-based clinical practice guidelines (2nd edition)
    Walter J Scott
    Fox Chase Cancer Center Suite C 312, 333 Cottman Ave, Philadelphia, PA 19111, USA
    Chest 132:234S-242S. 2007
    ..Adjuvant therapy (both chemotherapy and radiation therapy) and the use of larger fractions of radiotherapy delivered to a smaller area for nonoperative treatment of early stage NSCLC have shown promising results...
  5. ncbi Radiofrequency ablation of lung malignancies
    Christophe L Nguyen
    Department of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111-2497, USA
    Ann Thorac Surg 82:365-71. 2006
    ..This article addresses these issues and provides the thoracic surgeon with a current review of the application of radiofrequency ablation to lung tumors...
  6. ncbi The surgical management of superior sulcus tumors: a retrospective review with long-term follow-up
    Melvyn Goldberg
    Department of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111 2497, USA
    Ann Thorac Surg 79:1174-9. 2005
    ..We reviewed our experience with multimodality therapy for superior sulcus tumors to identify aspects of treatment that impact survival...
  7. ncbi Complete response to neoadjuvant chemoradiotherapy in esophageal carcinoma is associated with significantly improved survival
    Adam C Berger
    Department of Surgical Oncology, and Division of Biostatistics, Fox Chase Cancer Center, 333 Cottman Ave, Philadelphia, PA 19111, USA
    J Clin Oncol 23:4330-7. 2005
    ..0001 and P <.0002, respectively). CONCLUSION: Response to CRT and the ability to perform an R0 resection are associated with significantly improved survival in patients with esophageal carcinoma...
  8. ncbi Radiofrequency ablation of primary lung cancer: results from an ablate and resect pilot study
    Christophe L Nguyen
    Department of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, PA 19111-2497, USA
    Chest 128:3507-11. 2005
    ..Additional investigation with histopathologic correlation is needed to fully assess the long-term efficacy of RFA for NSCLC...
  9. ncbi Treatment of stage II non-small cell lung cancer
    Walter J Scott
    Department of Surgical Oncology, Section of Thoracic Surgical Oncology, Fox Chase Cancer Center, 7701 Burholme Avenue, Philadelphia, PA 19111, USA
    Chest 123:188S-201S. 2003
    ..Superior sulcus tumors are discussed elsewhere in these guidelines...
  10. ncbi Surgical treatment of other bronchial tumors
    Walter J Scott
    Department of Surgical Oncology, Section of Thoracic Surgical Oncology, Fox Chase Cancer Center, 7701 Burholme Avenue, Philadelphia, PA 19111, USA
    Chest Surg Clin N Am 13:111-28. 2003
    ..This article discusses the surgical treatment of each of these tumors individually...
  11. ncbi Surgical treatment of metastatic disease to the lung
    Roderick M Quiros
    Department of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, PA 19111 2497, USA
    Semin Oncol 35:134-46. 2008
    ....
  12. ncbi Invited commentary
    Walter J Scott
    Thoracic Surgical Oncology, Fox Chase Cancer Center, Philadelphia, PA 19111, USA
    Ann Thorac Surg 80:2040. 2005
  13. ncbi Noninvasive staging of esophageal carcinoma
    Adam C Berger
    Department of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA
    J Surg Res 117:127-33. 2004
  14. ncbi Positron emission tomography (PET) and combined imaging modalities for staging lung cancer
    Walter J Scott
    Fox Chase Cancer Center, Philadelphia, PA 19111, USA
    Surg Clin North Am 82:477-95. 2002
    ..Looking forward, sophisticated radiolabeling techniques promise to improve both the diagnostic accuracy of PET and our ability to deliver targeted cancer therapy to patients...